Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 8, 2012 · 10-Q · 38 days after period end · 0001193125-12-218890
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $2.97M | $3.24M |
| Net Income | $30.00K | -$207.00K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 8, 2012 · 38 d after period end
